InventHelp Inventor Develops Incontinence Accessory for Men (NWO-169)
PITTSBURGH, May 21, 2018 /PRNewswire/ -- "Men who experience urinary incontinence do not have many options when it comes to comfortable wetness protection," said an inventor from New Orleans, La. "Adult diapers are bulky and uncomfortable, which led me to develop slimmer, sleeker, more comforting protection."
He developed the patent-pending SLYDE ONS to absorb urine effectively. The accessory prevents urine from staining or soiling undergarments and bottoms. It keeps the penis dry and comfortable, which helps to reduce skin irritation and rashes. The device eliminates the need to wear bulky adult diapers. Furthermore, it features a comfortable, sleek design that is unobtrusive and discreet.
The original design was submitted to the New Orleans office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 17-NWO-169, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...
